Literature DB >> 19298843

Bmi1 deficient neural stem cells have increased integrin dependent adhesion to self-secreted matrix.

Sophia W M Bruggeman1, Danielle Hulsman, Maarten van Lohuizen.   

Abstract

BACKGROUND: Neural cells deficient for Polycomb group (PcG) protein Bmi1 are impaired in the formation and differentiation of high grade glioma, an incurable cancer of the brain. It was shown that mechanisms involved in cell adhesion and migration were specifically affected in these tumors.
METHODS: Using biochemical and cell biological approaches, we investigated the adhesive capacities of Bmi1;Ink4a/Arf deficient primary neural stem cells (NSCs).
RESULTS: Bmi1;Ink4a/Arf deficient NSCs have altered expression of Collagen-related genes, secrete increased amounts of extracellular matrix, and exhibit enhanced cell-matrix binding through the Beta-1 Integrin receptor. These traits are independent from the well described role of Bmi1 as repressor of the Ink4a/Arf tumor suppressor locus.
CONCLUSION: In addition to proliferative processes, Bmi1 controls the adhesive capacities of primary NSCs by modulating extracellular matrix secretion. GENERAL SIGNIFICANCE: Since PcG protein Bmi1 is important for both normal development and tumorigenesis, it is vital to understand the complete network in which this protein acts. Whereas it is clear that control of Ink4a/Arf is a major Bmi1 function, there is evidence that other downstream mechanisms exist. Hence, our novel finding that Bmi1 also governs cell adhesion significantly contributes to our understanding of the PcG proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298843     DOI: 10.1016/j.bbagen.2009.03.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.

Authors:  Aaron Cooper; John van Doorninck; Lingyun Ji; Darren Russell; Marc Ladanyi; Hiroyuki Shimada; Mark Krailo; Richard B Womer; Jessie Hao-ru Hsu; Dafydd Thomas; Timothy J Triche; Richard Sposto; Elizabeth R Lawlor
Journal:  Clin Cancer Res       Date:  2010-11-03       Impact factor: 12.531

2.  BMI-1, a promising therapeutic target for human cancer.

Authors:  Min-Cong Wang; Chun-Li Li; Jie Cui; Min Jiao; Tao Wu; L I Jing; Ke-Jun Nan
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

3.  mSEL-1L (Suppressor/enhancer Lin12-like) protein levels influence murine neural stem cell self-renewal and lineage commitment.

Authors:  Marina Cardano; Giuseppe R Diaferia; Monica Cattaneo; Sara S Dessì; Qiaoming Long; Luciano Conti; Pasquale Deblasio; Elena Cattaneo; Ida Biunno
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

4.  Mutations in the polycomb group gene polyhomeotic lead to epithelial instability in both the ovary and wing imaginal disc in Drosophila.

Authors:  Pierre Gandille; Karine Narbonne-Reveau; Elisabeth Boissonneau; Neel Randsholt; Denise Busson; Anne-Marie Pret
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

5.  Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.

Authors:  Franck Court; Elisa Le Boiteux; Anne Fogli; Mélanie Müller-Barthélémy; Catherine Vaurs-Barrière; Emmanuel Chautard; Bruno Pereira; Julian Biau; Jean-Louis Kemeny; Toufic Khalil; Lucie Karayan-Tapon; Pierre Verrelle; Philippe Arnaud
Journal:  Genome Res       Date:  2019-09-18       Impact factor: 9.043

6.  Brain cancer stem cells: current status on glioblastoma multiforme.

Authors:  Sabrina Facchino; Mohamed Abdouh; Gilbert Bernier
Journal:  Cancers (Basel)       Date:  2011-03-30       Impact factor: 6.639

7.  BMI1 represses Ink4a/Arf and Hox genes to regulate stem cells in the rodent incisor.

Authors:  Brian Biehs; Jimmy Kuang-Hsien Hu; Nicolas B Strauli; Eugenio Sangiorgi; Heekyung Jung; Ralf-Peter Heber; Sunita Ho; Alice F Goodwin; Jeremy S Dasen; Mario R Capecchi; Ophir D Klein
Journal:  Nat Cell Biol       Date:  2013-06-02       Impact factor: 28.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.